cobimetinib,vemurafenib,atezolizumab
roche,exelixis
['melanoma', 'cobimetinib', 'atezo', 'imspire150', 'vemurafenib']
overall survival (os) with first-line atezolizumab (a) or placebo (p) in combination with vemurafenib (v) and cobimetinib (c) in brafv600 mutation-positive advanced melanoma: second interim os analysis of the phase 3 imspire150 study #asco22 
Medicina Interna - Oncología Clínica - Profesor Titular @UPBColombia - Clínica Astorga. #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis